The transaction is anticipated to be completed in approximately three months subject to customary closing conditions, including HealthGate obtaining renewal agreements with certain existing customers and approval by its shareholders.
HealthGate is retaining its evidence-based medical guidelines and its Quality Architect and InteractiveIC products and services, which the company plans to continue developing, marketing and licensing to healthcare organizations.
The sale of our patient content products to EBSCO Publishing enables us to focus exclusively on the opportunities we see in quality improvement and risk management, said Bill Reece, HealthGate’s CEO. With flagship products and services such as InteractiveIC and Quality Architect, currently under development, HealthGate is well-poised to meet the growing demand for solutions that help healthcare organizations and institutions improve quality of care and better manage risk.
HealthGate’s patient content repository business includes its Health Outreach Toolkit, consumer Health Library, the HealthGateWay newsletter creation tool and health information, evidence-based fact sheets and in-depth reports on the most common conditions and treatments, interactive tools, drug information, medical news and specialty resources.
EBSCO Publishing said that the acquisition was a demonstration of its commitment to the fields of medicine and consumer health.
